符移才, 吴玉霞, 张俊焱, 伦宜然, 黄明敏. 2020年上半年《上海预防医学》投稿稿件与新冠肺炎刊出稿件的编撰分析[J]. 上海预防医学, 2021, 33(10): 978-986. DOI: 10.19428/j.cnki.sjpm.2021.21078
引用本文: 符移才, 吴玉霞, 张俊焱, 伦宜然, 黄明敏. 2020年上半年《上海预防医学》投稿稿件与新冠肺炎刊出稿件的编撰分析[J]. 上海预防医学, 2021, 33(10): 978-986. DOI: 10.19428/j.cnki.sjpm.2021.21078
FU Yi-cai, WU Yu-xia, ZHANG Jun-yan, LUN Yi-ran, HUANG Ming-min. Writing and editing of both contributed papers and publications in the first half year of 2020 from Shanghai Journal of Preventive Medicine[J]. Shanghai Journal of Preventive Medicine, 2021, 33(10): 978-986. DOI: 10.19428/j.cnki.sjpm.2021.21078
Citation: FU Yi-cai, WU Yu-xia, ZHANG Jun-yan, LUN Yi-ran, HUANG Ming-min. Writing and editing of both contributed papers and publications in the first half year of 2020 from Shanghai Journal of Preventive Medicine[J]. Shanghai Journal of Preventive Medicine, 2021, 33(10): 978-986. DOI: 10.19428/j.cnki.sjpm.2021.21078

2020年上半年《上海预防医学》投稿稿件与新冠肺炎刊出稿件的编撰分析

Writing and editing of both contributed papers and publications in the first half year of 2020 from Shanghai Journal of Preventive Medicine

  • 摘要:
    目的了解《上海预防医学》2020年上半年的收稿及刊出情况,特别是COVID-19论文的发表及刊出效果,为国内期刊在公共卫生热点中抢占先机提供借鉴。
    方法收集2020年上半年“1—6月”全部收稿稿件,分析其来源指标以及编辑处理情况。对2020年上半年刊出的6期杂志的所有文章进行来源指标、编辑处理和刊出效果(下载和引用)的分析。
    结果2020年上半年收稿450篇,录用129篇、录用率为28.67%。其中COVID-19为116篇、占比25.78%,录用32篇、占比24.81%。3月份投稿最多,且COVID-19也最多。不同研究领域(传染、妇儿、临床、慢性、社会、卫生、其他)都有分布,COVID-19的稿件主要集中于传染和社会两个领域。COVID-19稿件与非COVID-19相比,审稿专家数、返修天数、退修/录用天数更少,复制比也更低(均P<0.05)。上半年刊出的106篇稿件中,COVID-19稿件作者数更多、参考文献来源于政府公告者更多、外文参考文献数及≤5年参考文献数优于对照(均P<0.05)。刊出的COVID-19论文的刊出效果优于非COVID-19论文,校正下载为2 077.37次/年(vs对照为111.53次/年),校正引用为12.99次/年(vs 对照为0.49次/年)。可见,COVID-19稿件的社会影响力和学术影响力优于非COVID-19稿件(P<0.001)。
    结论《上海预防医学》2020年上半年的COVID-19稿件质量较好,对提升期刊论文质量和学术影响力贡献很大。提示学术期刊应当加强公共卫生热点问题的关注力度。

     

    Abstract:
    objectiveTo analyze the contributed papers and publications in the first half year of 2020 from Shanghai Journal of Preventive Medicine, especially the COVID-19 papers, to provide basis for the academic journals to win out during the public hot points.
    MethodsAll the papers contributed in the first half year of 2020 from Shanghai Journal of Preventive Medicine, were collected to analyze the sources parameters, editing parameters. All published papers were collected to analyze the sources parameters, editing parameters and their usages (downloads and citations).
    ResultsThere were 450 papers contributed in the first half year of 2020, 129 papers were accepted accounting for 28.67%. Among them, 116 papers were COVID-19 papers accounting for 25.78%, and 32 papers were accepted accounting for 24.81%. the March was the highest month of contribution, also for COVID-19 papers. Many academic domains such as infectious disease, women and children health, clinic science, chronic disease, social medicine, public hygiene and others were predominated among those papers. COVID-19 papers dominated in domains of infectious disease and social medicine. According to the non-COVID-19 papers, the COVID-19 papers had higher numbers of peer reviewers, lower days for back improvement, lower days for refusals or acceptance, also had lower copy percentages by plagiarism check (all P<0.05). there were 106 papers published in the first half year of 2020. Published COVID-19 papers had higher number of authors, higher numbers of references in term of governments reports, foreign references and less than 5 years references (all P<0.05). Those published COVID-19 papers had better usages than those no-COVID-19 papers, adjusted downloads were 2 077.37/year vs 111.53/year, adjusted citations were 12.99/year vs 0.49/year. It was obvious that the published COVID-19 papers had very excellent social influences and academic influences (P<0.001).
    ConclusionPublication in the first half year of 2020 from Shanghai Journal of Preventive Medicine is high-qualified and is good for the journal’s improvement in social influences and academic influences. It is important for academic journals to pay more attention to the hot points of public health accordingly.

     

/

返回文章
返回